Effect of a monoclonal antibody against human relaxin-2 on cancer cell growth inhibition

被引:3
|
作者
Park, Byoung Kwon [1 ,2 ]
Lee, Su In [2 ]
Lee, Younghee [3 ]
Cho, Sooyoung [4 ]
Lee, Young Seek [5 ]
Kwon, Hyung-Joo [1 ,2 ]
机构
[1] Hallym Univ, Coll Med, Ctr Med Sci Res, Chunchon 24252, South Korea
[2] Hallym Univ, Coll Med, Dept Microbiol, Chunchon 24252, South Korea
[3] Chungbuk Natl Univ, Dept Biochem, Coll Nat Sci, Cheongju 28644, South Korea
[4] Seoul Natl Univ, Res Inst Vet Sci BK21, Lab Dev Biol & Genom, Coll Vet Med,Program Vet Sci, Seoul 08826, South Korea
[5] Hanyang Univ, Div Mol & Life Sci, Coll Sci & Technol, Ansan 15588, South Korea
基金
新加坡国家研究基金会;
关键词
Cancer; Monoclonal antibody; Relaxin-2; DNA-LIPOSOME COMPLEX; XENOGRAFT TUMOR-GROWTH; CPG-DNA; INCREASES SECRETION; CERVICAL GROWTH; IN-VIVO; PROGRESSION; EXPRESSION; PIG; OSTEOSARCOMA;
D O I
10.1007/s13765-016-0221-4
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Relaxin-2 has gained much attention because of its importance in cancer cell proliferation, invasion, and angiogenesis. However, the potential of relaxin-2 as a target for immunotherapy has never been directly validated before. In the present study, we produced a human relaxin-2-specific antibody by immunizing mice using a specific liposome complex containing relaxin-2 epitope peptide and CpG-DNA. We isolated a hybridoma clone, 1B11F12, producing the anti-relaxin-2 monoclonal antibody. We confirmed with immunoprecipitation analysis that the antibody specifically recognizes native human relaxin-2. Treatment with the antibody suppressed the growth of some cancer cell lines. Therefore, we suggest that relaxin-2 could be a reasonable target of cancer therapeutics, and the monoclonal antibody could be used to treat cancer in humans.
引用
收藏
页码:739 / 746
页数:8
相关论文
共 50 条
  • [41] No Effect of Hepatic Impairment on the Pharmacokinetics of Serelaxin, a Recombinant Human Relaxin-2 in Development for the Treatment of Acute Heart Failure
    Kobalava, Zhanna
    Halabi, Atef
    Zahringer, Andreas
    Pang, Yinuo
    Dahlke, Marion
    CIRCULATION, 2013, 128 (22)
  • [42] Inhibition of tumor growth by a monoclonal antibody to human vascular endothelial growth factor.
    Wang, DZ
    Fang, SL
    Zheng, GY
    Yang, XC
    Lee, Y
    Nishitani, J
    Liu, X
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 495 - 495
  • [43] Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells
    Zhang, Youcheng
    Zhang, Yawu
    CANCER INVESTIGATION, 2008, 26 (03) : 230 - 236
  • [44] Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α-enolase
    López-Alemany, R
    Longstaff, C
    Hawley, S
    Mirshahi, M
    Fábregas, P
    Jardí, M
    Merton, E
    Miles, LA
    Félez, J
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 72 (04) : 234 - 242
  • [45] Panitumumab: Human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer
    Wu, Mel
    Rivkin, Anastasia
    Pham, Trinh
    CLINICAL THERAPEUTICS, 2008, 30 (01) : 14 - 30
  • [46] Population Pharmacokinetics of Rilotumumab, a Fully Human Monoclonal Antibody Against Hepatocyte Growth Factor, in Cancer Patients
    Zhu, Min
    Doshi, Sameer
    Gisleskog, Per O.
    Oliner, Kelly S.
    Perez Ruixo, Juan Jose
    Loh, Elwyn
    Zhang, Yilong
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (01) : 328 - 336
  • [47] Monoclonal Antibody Against Human Progranulin
    Xia, Haibin
    HYBRIDOMA, 2011, 30 (03): : 318 - 318
  • [48] Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen
    Suzuki, N.
    Tamada, Y.
    Shigirahara, K.
    Suzuki, A.
    Susumu, N.
    Ishida, I.
    Aoki, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) : 996 - 1006
  • [49] B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)
    Marshall, Sarah A.
    O'Sullivan, Kelly
    Ng, Hooi Hooi
    Bathgate, Ross A. D.
    Parry, Laura J.
    Hossain, Mohammed Akhter
    Leo, Chen Huei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 807 : 190 - 197
  • [50] INHIBITION OF AXONAL GROWTH BY A MONOCLONAL-ANTIBODY
    HENKEFAHLE, S
    BONHOEFFER, F
    NATURE, 1983, 303 (5912) : 65 - 67